Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Inflammatory Bowel Diseases

Free Subscription Articles published in Aliment Pharmacol Ther Retrieve available abstracts of 154 articles: HTML format

Single Articles

March 2008
1. HAWTHORNE AB , Rubin G, Ghosh S
   Review article: medication non-adherence in ulcerative colitis - strategies to improve adherence with mesalazine and other maintenance therapies.
   Aliment Pharmacol Ther. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
2. LICHTENSTEIN GR , Kamm MA, Sandborn WJ, Lyne A, et al
   MMX(trade mark) mesalazine for the induction of remission of mild-to-moderately active ulcerative colitis: efficacy and tolerability in specific patient sub-populations.
   Aliment Pharmacol Ther. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. HANAUER SB
   Review article: evolving concepts in treatment and disease modification in ulcerative colitis.
   Aliment Pharmacol Ther. 2008;27.
   PubMed     Related articles    Abstract available
   
   
   
4. ROBINSON A
   Review article: improving adherence to medication in patients with inflammatory bowel disease.
   Aliment Pharmacol Ther. 2008;27.
   PubMed     Related articles    Abstract available
   
   
   
5. WESTWOOD N , Travis SP
   Review article: what do patients with inflammatory bowel disease want for their clinical management?
   Aliment Pharmacol Ther. 2008;27.
   PubMed     Related articles    Abstract available
   
   
   February 2008
6. HO GT , Smith L, Aitken S, Lee HM, et al
   The use of adalimumab in the management of refractory Crohn's disease.
   Aliment Pharmacol Ther. 2008;27:308-15.
   PubMed     Related articles    Abstract available
   
   
   
7. DAY AS , Whitten KE, Sidler M, Lemberg DA, et al
   Systematic review: nutritional therapy in paediatric Crohn's disease.
   Aliment Pharmacol Ther. 2008;27:293-307.
   PubMed     Related articles    Abstract available
   
   
   
8. O DONNELL S , O Morain C
   Review article: the use of anti-TNF therapy in inflammatory bowel disease during pregnancy and conception.
   Aliment Pharmacol Ther. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
9. GUNESH S , Thomas GA, Williams GT, Roberts A, et al
   The incidence of Crohn's disease in Cardiff over the last 75 years: an update for 1996-2005.
   Aliment Pharmacol Ther. 2008;27:211-9.
   PubMed     Related articles    Abstract available
   
   
   
10. LATIANO A , Palmieri O, Valvano MR, D'Inca R, et al
    The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
    Aliment Pharmacol Ther. 2008;27:241-8.
    PubMed     Related articles    Abstract available
    
    
    January 2008
11. DE SCHEPPER HU , De Man JG, Moreels TG, Pelckmans PA, et al
    Review article: gastrointestinal sensory and motor disturbances in inflammatory bowel disease - clinical relevance and pathophysiological mechanisms.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
12. D'INCA R , Bertomoro P, Mazzocco K, Vettorato MG, et al
    Risk factors for non-adherence to medication in inflammatory bowel disease patients.
    Aliment Pharmacol Ther. 2008;27:166-72.
    PubMed     Related articles    Abstract available
    
    
    
13. ROEDIGER WE
    Review article: nitric oxide (NO) from dysbiotic bacterial respiration of nitrate in the pathogenesis and as a target for therapy of ulcerative colitis.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
14. NOBLE CL , McCullough J, Ho W, Lees CW, et al
    Low body mass not vitamin d receptor polymorphisms predict osteoporosis in patients with inflammatory bowel disease.
    Aliment Pharmacol Ther. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
15. AKOBENG AK
    Review article: the evidence base for interventions used to maintain remission in Crohn's disease.
    Aliment Pharmacol Ther. 2008;27:11-8.
    PubMed     Related articles    Abstract available
    
    
    December 2007
16. KAPLAN GG , Hur C, Korzenik J, Sands BE, et al
    Infliximab dose escalation vs. initiation of adalimumab for loss of response in Crohn's disease: a cost-effectiveness analysis.
    Aliment Pharmacol Ther. 2007;26.
    PubMed     Related articles    Abstract available
    
    
    
17. HASSAN C , Zullo A, De Francesco V, Ierardi E, et al
    Systematic review: Endoscopic dilatation in Crohn's disease.
    Aliment Pharmacol Ther. 2007;26.
    PubMed     Related articles    Abstract available
    
    
    
18. WEERSMA RK , van Dullemen HM, van der Steege G, Nolte IM, et al
    Review article: Inflammatory bowel disease and genetics.
    Aliment Pharmacol Ther. 2007;26 Suppl 2:57-65.
    PubMed     Related articles    Abstract available
    
    
    
19. TAMINIAU JA
    Review article: The clinical importance of growth in children with inflammatory bowel disease: is it important to the gastroenterologist?
    Aliment Pharmacol Ther. 2007;26 Suppl 2:53-6.
    PubMed     Related articles    Abstract available
    
    
    
20. VLEGGAAR FP , Lutgens MW, Claessen MM
    Review article: The relevance of surveillance endoscopy in long-lasting inflammatory bowel disease.
    Aliment Pharmacol Ther. 2007;26 Suppl 2:47-52.
    PubMed     Related articles    Abstract available
    
    
    
21. JONKERS D , Stockbrugger R
    Review article: Probiotics in gastrointestinal and liver diseases.
    Aliment Pharmacol Ther. 2007;26 Suppl 2:133-48.
    PubMed     Related articles    Abstract available
    
    
    
22. VAN DEN BROEK FJ , Fockens P, Dekker E
    Review article: New developments in colonic imaging.
    Aliment Pharmacol Ther. 2007;26 Suppl 2:91-9.
    PubMed     Related articles    Abstract available
    
    
    November 2007
23. SARO C , da la Coba C, Casado MA, Morales JM, et al
    Resource use in patients with Crohn's disease treated with infliximab.
    Aliment Pharmacol Ther. 2007;26:1313-23.
    PubMed     Related articles    Abstract available
    
    
    
24. ARATARI A , Papi C, Leandro G, Viscido A, et al
    Early versus late surgery for ileo-caecal Crohn's disease.
    Aliment Pharmacol Ther. 2007;26:1303-12.
    PubMed     Related articles    Abstract available
    
    
    
25. RHODES JM , Robinson R, Beales I, Pugh S, et al
    Clinical trial: oral prednisolone metasulfobenzoate (predocol) versus oral prednisolone for active ulcerative colitis.
    Aliment Pharmacol Ther. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
26. LEES CW , Mann A, Hansoni B, Arnott SJ, et al
    Tolerability and safety of mercaptopurine in azathioprine intolerant patients with inflammatory bowel disease.
    Aliment Pharmacol Ther. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
27. ELIAKIM R , Tulassay Z, Kupcinskas L, Adamonis K, et al
    Clinical trial: randomized-controlled clinical study comparing the efficacy and safety of a low-volume vs. a high-volume mesalazine foam in active distal ulcerative colitis.
    Aliment Pharmacol Ther. 2007;26:1237-49.
    PubMed     Related articles    Abstract available
    
    
    
28. SAFDI AV , Cohen RD
    Review article: increasing the dose of oral mesalazine therapy for active ulcerative colitis does not improve remission rates.
    Aliment Pharmacol Ther. 2007;26:1179-86.
    PubMed     Related articles    Abstract available
    
    
    October 2007
29. THEIS VS , Rhodes JM
    Review article: minimising Tuberculosis during anti-TNF-alpha treatment of inflammatory bowel disease.
    Aliment Pharmacol Ther. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
30. GERASIMIDIS K , McGrogan P, Hassan K, Edwards CA, et al
    Dietary modifications, nutritional supplements and alternative medicine in paediatric patients with inflammatory bowel disease.
    Aliment Pharmacol Ther. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
31. NGUYEN GC , Laveist TA, Brant SR
    The utilisation of parenteral nutrition during the inpatient management of inflammatory bowel disease in the United States - a national survey.
    Aliment Pharmacol Ther. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
32. WINTER JW , Marinaki AM, Sanderson JD, Mills PR, et al
    TPMT genotype and the response to azathioprine in inflammatory bowel disease: authors' reply.
    Aliment Pharmacol Ther. 2007;26:1084-5.
    PubMed     Related articles   
    
    
    
33. STOCCO G , Martelossi S, Decorti G, Bartoli F, et al
    Thiopurine-S-methyltransferase genotype and the response to azathioprine in inflammatory bowel disease.
    Aliment Pharmacol Ther. 2007;26:1083-4.
    PubMed     Related articles   
    
    
    
34. BUNING C , Schmidt HH, Molnar T, DE Jong DJ, et al
    Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis.
    Aliment Pharmacol Ther. 2007;26:1025-33.
    PubMed     Related articles    Abstract available
    
    
    
35. NEWNHAM E , Hawkes E, Surender A, James SL, et al
    Quantifying exposure to diagnostic medical radiation in patients with inflammatory bowel disease: are we contributing to malignancy?
    Aliment Pharmacol Ther. 2007;26:1019-24.
    PubMed     Related articles    Abstract available
    
    
    
36. SCHRODER O , Naumann M, Shastri Y, Povse N, et al
    Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin.
    Aliment Pharmacol Ther. 2007;26:1035-42.
    PubMed     Related articles    Abstract available
    
    
    
37. ESRAILIAN E , Spiegel BM, Targownik LE, Dubinsky MC, et al
    Differences in the management of Crohn's disease among experts and community providers, based on a national survey of sample case vignettes.
    Aliment Pharmacol Ther. 2007;26:1005-18.
    PubMed     Related articles    Abstract available
    
    
    
38. SANDBORN WJ , Feagan BG, Lichtenstein GR
    Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remission.
    Aliment Pharmacol Ther. 2007;26:987-1003.
    PubMed     Related articles    Abstract available
    
    
    September 2007
39. JUYAL G , Amre D, Midha V, Sood A, et al
    Evidence of allelic heterogeneity for associations between NOD2/CARD15 gene and ulcerative colitis among North Indians.
    Aliment Pharmacol Ther. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
40. PORRO GB , Cassinotti A, Ferrara E, Maconi G, et al
    Review article: the management of steroid dependency in ulcerative colitis.
    Aliment Pharmacol Ther. 2007;26:779-94.
    PubMed     Related articles    Abstract available
    
    
    
41. BELL AJ , Price AB, Forbes A, Ciclitira PJ, et al
    Pre-pouch ileitis.
    Aliment Pharmacol Ther. 2007;26:963-4.
    PubMed     Related articles   
    
    
    
42. DZIECHCIARZ P , Horvath A, Shamir R, Szajewska H, et al
    Meta-analysis: enteral nutrition in active Crohn's disease in children.
    Aliment Pharmacol Ther. 2007;26:795-806.
    PubMed     Related articles    Abstract available
    
    
    
43. KOHN A , Daperno M, Armuzzi A, Cappello M, et al
    Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up.
    Aliment Pharmacol Ther. 2007;26:747-56.
    PubMed     Related articles    Abstract available
    
    
    
44. SHEN J , Ran ZH, Tong JL, Xiao SD, et al
    Meta-analysis: the utility and safety of heparin in the treatment of active ulcerative colitis.
    Aliment Pharmacol Ther. 2007;26:653-63.
    PubMed     Related articles    Abstract available
    
    
    
45. VAN DIEREN JM , Hansen BE, Kuipers EJ, Nieuwenhuis EE, et al
    Meta-analysis: inosine triphosphate pyrophosphatase polymorphisms and thiopurine toxicity in the treatment of inflammatory bowel disease.
    Aliment Pharmacol Ther. 2007;26:643-52.
    PubMed     Related articles    Abstract available
    
    
    
46. PALMIERI O , Latiano A, Bossa F, Vecchi M, et al
    Sequential evaluation of thiopurine methyltransferase, inosine triphosphate pyrophosphatase, and HPRT1 genes polymorphisms to explain thiopurines' toxicity and efficacy.
    Aliment Pharmacol Ther. 2007;26:737-45.
    PubMed     Related articles    Abstract available
    
    
    August 2007
47. HEETUN ZS , Byrnes C, Neary P, O'morain C, et al
    Review article: reproduction in the patient with inflammatory bowel disease.
    Aliment Pharmacol Ther. 2007;26:513-33.
    PubMed     Related articles    Abstract available
    
    
    
48. LEES CW , Heys D, Ho GT, Noble CL, et al
    A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis.
    Aliment Pharmacol Ther. 2007;26:411-9.
    PubMed     Related articles    Abstract available
    
    
    
49. MANSFIELD JC , Parkes M, Hawthorne AB, Forbes A, et al
    A randomized, double-blind, placebo-controlled trial of lenalidomide in the treatment of moderately severe active Crohn's disease.
    Aliment Pharmacol Ther. 2007;26:421-30.
    PubMed     Related articles    Abstract available
    
    
    
50. IRVING PM , Gearry RB, Sparrow MP, Gibson PR, et al
    Review article: appropriate use of corticosteroids in Crohn's disease.
    Aliment Pharmacol Ther. 2007;26:313-29.
    PubMed     Related articles    Abstract available
    
    
    July 2007
51. SANDBORN WJ , Kamm MA, Lichtenstein GR, Lyne A, et al
    MMX Multi Matrix System((R)) mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double-blind, placebo-controlled trials.
    Aliment Pharmacol Ther. 2007;26:205-15.
    PubMed     Related articles    Abstract available
    
    
    
52. BOKEMEYER B , Teml A, Roggel C, Hartmann P, et al
    Adherence to thiopurine treatment in out-patients with Crohn's disease.
    Aliment Pharmacol Ther. 2007;26:217-25.
    PubMed     Related articles    Abstract available
    
    
    
53. MANGUSO F , Balzano A
    Meta-analysis: the efficacy of rectal beclomethasone dipropionate vs. 5-aminosalicylic acid in mild to moderate distal ulcerative colitis.
    Aliment Pharmacol Ther. 2007;26:21-9.
    PubMed     Related articles    Abstract available
    
    
    June 2007
54. TREMAINE WJ , Timmons LJ, Loftus EV Jr, Pardi DS, et al
    Age at onset of inflammatory bowel disease and the risk of surgery for non-neoplastic bowel disease.
    Aliment Pharmacol Ther. 2007;25:1435-41.
    PubMed     Related articles    Abstract available
    
    
    
55. CHU EC , Chai J, Ahluwalia A, Tarnawski AS, et al
    Mesalazine downregulates c-Myc in human colon cancer cells. A key to its chemopreventive action?
    Aliment Pharmacol Ther. 2007;25:1443-9.
    PubMed     Related articles    Abstract available
    
    
    
56. STEINHART AH , Forbes A, Mills EC, Rodgers-Gray BS, et al
    Systematic review: the potential influence of mesalazine formulation on maintenance of remission in Crohn's disease.
    Aliment Pharmacol Ther. 2007;25:1389-99.
    PubMed     Related articles    Abstract available
    
    
    
57. EPSTEIN D , Watermeyer G, Kirsch R
    Review article: the diagnosis and management of Crohn's disease in populations with high-risk rates for tuberculosis.
    Aliment Pharmacol Ther. 2007;25:1373-88.
    PubMed     Related articles    Abstract available
    
    
    
58. CREED TJ , Probert C
    Pulse cyclophosphamide in steroid-resistant inflammatory bowel disease: authors' reply.
    Aliment Pharmacol Ther. 2007;25:1364.
    PubMed     Related articles   
    
    
    
59. BARTA Z , Zold E, Zeher M
    Pulse cyclophosphamide in steroid-resistant inflammatory bowel disease.
    Aliment Pharmacol Ther. 2007;25:1363-4.
    PubMed     Related articles   
    
    
    
60. CALABRESE C , Fabbri A, Gionchetti P, Rizzello F, et al
    Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis.
    Aliment Pharmacol Ther. 2007;25:1311-6.
    PubMed     Related articles    Abstract available
    
    
    May 2007
61. GIONCHETTI P , Rizzello F, Poggioli G, Pierangeli F, et al
    Oral budesonide in the treatment of chronic refractory pouchitis.
    Aliment Pharmacol Ther. 2007;25:1231-6.
    PubMed     Related articles    Abstract available
    
    
    
62. WINTER JW , Gaffney D, Shapiro D, Spooner RJ, et al
    Assessment of thiopurine methyltransferase enzyme activity is superior to genotype in predicting myelosuppression following azathioprine therapy in patients with inflammatory bowel disease.
    Aliment Pharmacol Ther. 2007;25:1069-77.
    PubMed     Related articles    Abstract available
    
    
    
63. CASELLAS F , Borruel N, Torrejon A, Varela E, et al
    Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin.
    Aliment Pharmacol Ther. 2007;25:1061-1067.
    PubMed     Related articles    Abstract available
    
    
    
64. JAKOBOVITS SL , Jewell DP, Travis SP
    Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006.
    Aliment Pharmacol Ther. 2007;25:1055-60.
    PubMed     Related articles    Abstract available
    
    
    April 2007
65. OOI CY , Bohane TD, Lee D, Naidoo D, et al
    Thiopurine metabolite monitoring in paediatric inflammatory bowel disease.
    Aliment Pharmacol Ther. 2007;25:941-7.
    PubMed     Related articles    Abstract available
    
    
    
66. MIELE E , Pascarella F, Quaglietta L, Giannetti E, et al
    Altered intestinal permeability is predictive of early relapse in children with steroid-responsive ulcerative colitis.
    Aliment Pharmacol Ther. 2007;25:933-9.
    PubMed     Related articles    Abstract available
    
    
    
67. LJUNG T , Axelsson LG, Herulf M, Lundberg JO, et al
    Early changes in rectal nitric oxide and mucosal inflammatory mediators in Crohn's colitis in response to infliximab treatment.
    Aliment Pharmacol Ther. 2007;25:925-32.
    PubMed     Related articles    Abstract available
    
    
    
68. CANAVAN C , Abrams KR, Mayberry JF
    Meta-analysis: mortality in Crohn's disease.
    Aliment Pharmacol Ther. 2007;25:861-70.
    PubMed     Related articles    Abstract available
    
    
    
69. VIAZIS N , Karamanolis DG
    Indeterminate colitis--the role of wireless capsule endoscopy.
    Aliment Pharmacol Ther. 2007;25:859.
    PubMed     Related articles   
    
    
    
70. ROBLIN X , Phelip JM, Genevois M, Ducros V, et al
    Hyperhomocysteinaemia is associated with osteoporosis in patients with Crohn's disease.
    Aliment Pharmacol Ther. 2007;25:797-804.
    PubMed     Related articles    Abstract available
    
    
    
71. SEIDERER J , Brand S, Dambacher J, Pfennig S, et al
    Adalimumab in patients with Crohn's disease--safety and efficacy in an open-label single centre study.
    Aliment Pharmacol Ther. 2007;25:787-96.
    PubMed     Related articles    Abstract available
    
    
    March 2007
72. THOMAS T , Abrams KA, Robinson RJ, Mayberry JF, et al
    Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis.
    Aliment Pharmacol Ther. 2007;25:657-68.
    PubMed     Related articles    Abstract available
    
    
    
73. PEYRIN-BIROULET L , Laclotte C, Bigard MA
    Adalimumab maintenance therapy for Crohn's disease with intolerance or lost response to infliximab: an open-label study.
    Aliment Pharmacol Ther. 2007;25:675-80.
    PubMed     Related articles    Abstract available
    
    
    
74. PLAMONDON S , Ng SC, Kamm MA
    Thalidomide in luminal and fistulizing Crohn's disease resistant to standard therapies.
    Aliment Pharmacol Ther. 2007;25:557-67.
    PubMed     Related articles    Abstract available
    
    
    February 2007
75. SUBRAMANIAN V , Banerjee A, Beharry N, Farthing MJ, et al
    Determining the proximal extent of ulcerative colitis: white cell scan correlates well with histological assessment.
    Aliment Pharmacol Ther. 2007;25:441-6.
    PubMed     Related articles    Abstract available
    
    
    
76. LAZZERINI M , Martelossi S, Marchetti F, Scabar A, et al
    Efficacy and safety of thalidomide in children and young adults with intractable inflammatory bowel disease: long-term results.
    Aliment Pharmacol Ther. 2007;25:419-27.
    PubMed     Related articles    Abstract available
    
    
    
77. SZALAI AJ , Alarcon GS
    C-reactive protein polymorphism and Crohn's disease.
    Aliment Pharmacol Ther. 2007;25:519.
    PubMed     Related articles   
    
    
    
78. ALVAREZ-LOBOS M , Arostegui JI, Sans M, Tassies D, et al
    Combined type-1 plasminogen activator inhibitor and NOD2/CARD15 genotyping predicts complicated Crohn's disease behaviour.
    Aliment Pharmacol Ther. 2007;25:429-40.
    PubMed     Related articles    Abstract available
    
    
    
79. HINOJOSA J , Gomollon F, Garcia S, Bastida G, et al
    Efficacy and safety of short-term adalimumab treatment in patients with active Crohn's disease who lost response or showed intolerance to infliximab: a prospective, open-label, multicentre trial.
    Aliment Pharmacol Ther. 2007;25:409-18.
    PubMed     Related articles    Abstract available
    
    
    
80. HIGGINS PD , Leung J, Schwartz M, Mapili J, et al
    The quantitative validation of non-endoscopic disease activity indices in ulcerative colitis.
    Aliment Pharmacol Ther. 2007;25:333-42.
    PubMed     Related articles    Abstract available
    
    
    January 2007
81. CREED TJ , Probert CS
    Review article: steroid resistance in inflammatory bowel disease - mechanisms and therapeutic strategies.
    Aliment Pharmacol Ther. 2007;25:111-22.
    PubMed     Related articles    Abstract available
    
    
    
82. DESAI D , Faubion WA, Sandborn WJ
    Review article: biological activity markers in inflammatory bowel disease.
    Aliment Pharmacol Ther. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
83. GISBERT JP , Gonzalez-Lama Y, Mate J
    Systematic review: Infliximab therapy in ulcerative colitis.
    Aliment Pharmacol Ther. 2007;25:19-37.
    PubMed     Related articles    Abstract available
    
    
    
84. YAMAMOTO T , Nakahigashi M, Umegae S, Kitagawa T, et al
    Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn's disease: A prospective, non-randomized, parallel, controlled study.
    Aliment Pharmacol Ther. 2007;25:67-72.
    PubMed     Related articles    Abstract available
    
    
    
85. CANAVAN C , Abrams KR, Hawthorne B, Mayberry JF, et al
    Long-term prognosis in Crohn's disease: An epidemiological study of patients diagnosed more than 20 years ago in Cardiff.
    Aliment Pharmacol Ther. 2007;25:59-65.
    PubMed     Related articles    Abstract available
    
    
    
86. VERMEIRE S , van Assche G, Rutgeerts P
    Review article: Altering the natural history of Crohn's disease--evidence for and against current therapies.
    Aliment Pharmacol Ther. 2007;25:3-12.
    PubMed     Related articles    Abstract available
    
    
    December 2006
87. YOSHIDA N , Isozaki Y, Takagi T, Takenaka S, et al
    Review article: anti-tryptase therapy in inflammatory bowel disease.
    Aliment Pharmacol Ther. 2006;24 Suppl 4:249-55.
    PubMed     Related articles    Abstract available
    
    
    
88. TAKAGI T , Naito Y, Tsuboi H, Isozaki Y, et al
    Increased intestinal luminal carbon monoxide gas in patients with ulcerative colitis.
    Aliment Pharmacol Ther. 2006;24 Suppl 4:233-8.
    PubMed     Related articles    Abstract available
    
    
    
89. OKUDA T , Azuma T, Ohtani M, Matsunaga S, et al
    Hypoxia-inducible factor-1 alpha and vascular endothelial growth factor expression in ischaemic colitis and ulcerative colitis.
    Aliment Pharmacol Ther. 2006;24 Suppl 4:182-8.
    PubMed     Related articles    Abstract available
    
    
    
90. WATANABE K , Oshitani N, Kamata N, Inagawa M, et al
    Efficacy and endoscopic prediction of cytapheresis therapy in patients with refractory and steroid-dependent ulcerative colitis.
    Aliment Pharmacol Ther. 2006;24 Suppl 4:147-52.
    PubMed     Related articles    Abstract available
    
    
    
91. KULNIGG S , Gasche C
    Systematic review: managing anaemia in Crohn's disease.
    Aliment Pharmacol Ther. 2006;24.
    PubMed     Related articles    Abstract available
    
    
    November 2006
92. HERRLINGER KR , Jewell DP
    Review article: interactions between genotype and response to therapy in inflammatory bowel diseases.
    Aliment Pharmacol Ther. 2006;24:1403-12.
    PubMed     Related articles    Abstract available
    
    
    
93. TAKAGI S , Utsunomiya K, Kuriyama S, Yokoyama H, et al
    Effectiveness of an 'half elemental diet' as maintenance therapy for Crohn's disease: A randomized-controlled trial.
    Aliment Pharmacol Ther. 2006;24:1333-40.
    PubMed     Related articles    Abstract available
    
    
    
94. BRESSLER B , Sands BE
    Review article: Medical therapy for fistulizing Crohn's disease.
    Aliment Pharmacol Ther. 2006;24:1283-93.
    PubMed     Related articles    Abstract available
    
    
    October 2006
95. GASSULL MA
    Review article: the intestinal lumen as a therapeutic target in inflammatory bowel disease.
    Aliment Pharmacol Ther. 2006;24 Suppl 3:90-5.
    PubMed     Related articles    Abstract available
    
    
    
96. ORESLAND T
    Review article: colon-saving medical therapy vs. colectomy in ulcerative colitis - the case for colectomy.
    Aliment Pharmacol Ther. 2006;24 Suppl 3:74-9.
    PubMed     Related articles    Abstract available
    
    
    
97. STANGE EF
    Review article: the effect of aminosalicylates and immunomodulation on cancer risk in inflammatory bowel disease.
    Aliment Pharmacol Ther. 2006;24 Suppl 3:64-7.
    PubMed     Related articles    Abstract available
    
    
    
98. OBRADOR A , Ginard D, Barranco L
    Review article: colorectal cancer surveillance in ulcerative colitis - what should we be doing?
    Aliment Pharmacol Ther. 2006;24 Suppl 3:56-63.
    PubMed     Related articles    Abstract available
    
    
    
99. GEBOES K
    Review article: what are the important endoscopic lesions for detection of dysplasia in inflammatory bowel disease?
    Aliment Pharmacol Ther. 2006;24 Suppl 3:50-5.
    PubMed     Related articles    Abstract available
    
    
    
100. LOPEZ-SANROMAN A , Bermejo F
     Review article: how to control and improve adherence to therapy in inflammatory bowel disease.
     Aliment Pharmacol Ther. 2006;24.
     PubMed     Related articles    Abstract available
     
     
     
101. HANAUER SB
     Review article: high-dose aminosalicylates to induce and maintain remissions in ulcerative colitis.
     Aliment Pharmacol Ther. 2006;24 Suppl 3:37-40.
     PubMed     Related articles    Abstract available
     
     
     
102. SEKSIK P , Sokol H, Lepage P, Vasquez N, et al
     Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease.
     Aliment Pharmacol Ther. 2006;24 Suppl 3:11-8.
     PubMed     Related articles    Abstract available
     
     
     
103. VERMEIRE S
     Review article: genetic susceptibility and application of genetic testing in clinical management of inflammatory bowel disease.
     Aliment Pharmacol Ther. 2006;24 Suppl 3:2-10.
     PubMed     Related articles    Abstract available
     
     
     
104. GASSULL MA , Obrador A
     Introduction: new approaches to the detection and management of inflammatory bowel disease: from genetic testing to treatment strategies.
     Aliment Pharmacol Ther. 2006;24 Suppl 3:1.
     PubMed     Related articles   
     
     
     
105. D'HAENS G , Hommes D, Engels L, Baert F, et al
     Once daily MMX mesalazine for the treatment of mild-to-moderate ulcerative colitis: a phase II, dose-ranging study.
     Aliment Pharmacol Ther. 2006;24:1087-97.
     PubMed     Related articles    Abstract available
     
     
     
106. THALMAIER D , Dambacher J, Seiderer J, Konrad A, et al
     The +1059G/C polymorphism in the C-reactive protein (CRP) gene is associated with involvement of the terminal ileum and decreased serum CRP levels in patients with Crohn's disease.
     Aliment Pharmacol Ther. 2006;24:1105-15.
     PubMed     Related articles    Abstract available
     
     
     
107. KANE S , Dixon L
     Adherence rates with infliximab therapy in Crohn's disease.
     Aliment Pharmacol Ther. 2006;24:1099-103.
     PubMed     Related articles    Abstract available
     
     
     
108. KAMM MA
     Review article: biological drugs in Crohn's disease.
     Aliment Pharmacol Ther. 2006;24 Suppl 3:80-9.
     PubMed     Related articles    Abstract available
     
     
     
109. SCHOLMERICH J
     Review article: should we treat symptoms or lesions in Crohn's disease? The case for treating symptoms.
     Aliment Pharmacol Ther. 2006;24 Suppl 3:33-6.
     PubMed     Related articles    Abstract available
     
     
     
110. RUTGEERTS P
     Review article: recurrence of Crohn's disease after surgery - the need for treatment of new lesions.
     Aliment Pharmacol Ther. 2006;24 Suppl 3:29-32.
     PubMed     Related articles    Abstract available
     
     
     
111. LEMANN M
     Review article: can post-operative recurrence in Crohn's disease be prevented?
     Aliment Pharmacol Ther. 2006;24 Suppl 3:22-8.
     PubMed     Related articles    Abstract available
     
     
     
112. BAR-MEIR S
     Review article: capsule endoscopy - are all small intestinal lesions Crohn's disease?
     Aliment Pharmacol Ther. 2006;24 Suppl 3:19-21.
     PubMed     Related articles    Abstract available
     
     
     September 2006
113. DERIJKS LJ , Gilissen LP, Hooymans PM, Hommes DW, et al
     Review article: thiopurines in inflammatory bowel disease.
     Aliment Pharmacol Ther. 2006;24:715-29.
     PubMed     Related articles    Abstract available
     
     
     
114. ORCHARD T , Probert CS, Keshav S
     Review article: maintenance therapy in patients with ulcerative colitis.
     Aliment Pharmacol Ther. 2006;24 Suppl 1:17-22.
     PubMed     Related articles    Abstract available
     
     
     
115. TRAVIS SP
     Review article: induction therapy for patients with active ulcerative colitis.
     Aliment Pharmacol Ther. 2006;24 Suppl 1:10-6.
     PubMed     Related articles    Abstract available
     
     
     
116. TRAVIS SP
     Editorial: mesalazine in ulcerative colitis - is it time to revise treatment guidelines in the UK?
     Aliment Pharmacol Ther. 2006;24 Suppl 1:1.
     PubMed     Related articles   
     
     
     
117. DUBURQUE C , Lelong J, Iacob R, Seddik M, et al
     Successful induction of tolerance to infliximab in patients with Crohn's disease and prior severe infusion reactions.
     Aliment Pharmacol Ther. 2006;24:851-8.
     PubMed     Related articles    Abstract available
     
     
     
118. MACFARLANE S , Macfarlane GT, Cummings JH
     Review article: prebiotics in the gastrointestinal tract.
     Aliment Pharmacol Ther. 2006;24:701-14.
     PubMed     Related articles    Abstract available
     
     
     
119. DESREUMAUX P , Ghosh S
     Review article: mode of action and delivery of 5-aminosalicylic acid - new evidence.
     Aliment Pharmacol Ther. 2006;24 Suppl 1:2-9.
     PubMed     Related articles    Abstract available
     
     
     August 2006
120. HARBORD MW , Marks DJ, Forbes A, Bloom SL, et al
     Impaired neutrophil chemotaxis in Crohn's disease relates to reduced production of chemokines and can be augmented by granulocyte-colony stimulating factor.
     Aliment Pharmacol Ther. 2006;24:651-60.
     PubMed     Related articles    Abstract available
     
     
     
121. COHEN RD
     Review article: evolutionary advances in the delivery of aminosalicylates for the treatment of ulcerative colitis.
     Aliment Pharmacol Ther. 2006;24:465-74.
     PubMed     Related articles    Abstract available
     
     
     July 2006
122. HINDORF U , Lindqvist M, Hildebrand H, Fagerberg U, et al
     Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease.
     Aliment Pharmacol Ther. 2006;24:331-42.
     PubMed     Related articles    Abstract available
     
     
     
123. HO GT , Chiam P, Drummond H, Loane J, et al
     The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort.
     Aliment Pharmacol Ther. 2006;24:319-30.
     PubMed     Related articles    Abstract available
     
     
     
124. KEVANS D , Keegan D, Mulcahy HE, O'Donoghue DP, et al
     Infliximab therapy in Crohn's disease: a pragmatic approach?
     Aliment Pharmacol Ther. 2006;24:351-9.
     PubMed     Related articles    Abstract available
     
     
     
125. SCHMIDT C , Wittig BM, Moser C, Zeitz M, et al
     Cyclophosphamide pulse therapy followed by azathioprine or methotrexate induces long-term remission in patients with steroid-refractory Crohn's disease.
     Aliment Pharmacol Ther. 2006;24:343-50.
     PubMed     Related articles    Abstract available
     
     
     June 2006
126. ZOCCO MA , Dal Verme LZ, Cremonini F, Piscaglia AC, et al
     Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis.
     Aliment Pharmacol Ther. 2006;23:1567-74.
     PubMed     Related articles    Abstract available
     
     
     
127. LAHARIE D , Zerbib F, Adhoute X, Boue-Lahorgue X, et al
     Diagnosis of liver fibrosis by transient elastography (FibroScan) and non-invasive methods in Crohn's disease patients treated with methotrexate.
     Aliment Pharmacol Ther. 2006;23:1621-8.
     PubMed     Related articles    Abstract available
     
     
     May 2006
128. CREED TJ , Probert CS, Norman MN, Moorghen M, et al
     Basiliximab for the treatment of steroid-resistant ulcerative colitis: further experience in moderate and severe disease.
     Aliment Pharmacol Ther. 2006;23:1435-42.
     PubMed     Related articles    Abstract available
     
     
     
129. MINER PB JR , Geary RS, Matson J, Chuang E, et al
     Bioavailability and therapeutic activity of alicaforsen (ISIS 2302) administered as a rectal retention enema to subjects with active ulcerative colitis.
     Aliment Pharmacol Ther. 2006;23:1427-34.
     PubMed     Related articles    Abstract available
     
     
     
130. VAN DEVENTER SJ , Wedel MK, Baker BF, Xia S, et al
     A Phase II dose ranging, double-blind, placebo-controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left-sided ulcerative colitis.
     Aliment Pharmacol Ther. 2006;23:1415-25.
     PubMed     Related articles    Abstract available
     
     
     
131. MINER PB JR , Wedel MK, Xia S, Baker BF, et al
     Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left-sided ulcerative colitis: a randomized, double-blind, active-controlled trial.
     Aliment Pharmacol Ther. 2006;23:1403-13.
     PubMed     Related articles    Abstract available
     
     
     
132. D'INCA R , Annese V, di Leo V, Latiano A, et al
     Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease.
     Aliment Pharmacol Ther. 2006;23:1455-61.
     PubMed     Related articles    Abstract available
     
     
     
133. ZEZOS P , Papaioannou G, Nikolaidis N, Patsiaoura K, et al
     Low-molecular-weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study.
     Aliment Pharmacol Ther. 2006;23:1443-1453.
     PubMed     Related articles    Abstract available
     
     
     April 2006
134. WINTER J , Mills PR
     Impracticalities of thiopurine-S-methyltransferase determination in daily inflammatory bowel disease practice: authors' reply.
     Aliment Pharmacol Ther. 2006;23:1279-80.
     PubMed     Related articles   
     
     
     
135. DE BOER NK , Mulder CJ, Van Bodegraven AA
     Impracticalities of thiopurine S-methyltransferase determination in daily inflammatory bowel disease practice.
     Aliment Pharmacol Ther. 2006;23:1278-9.
     PubMed     Related articles   
     
     
     
136. DE SILVA A , Rampton DS
     Treatment of anaemia in inflammatory bowel disease: authors' reply.
     Aliment Pharmacol Ther. 2006;23:1274-5.
     PubMed     Related articles   
     
     
     
137. KOUTROUBAKIS IE , Karmiris K, Kouroumalis EA
     Treatment of anaemia in inflammatory bowel disease.
     Aliment Pharmacol Ther. 2006;23:1273-4.
     PubMed     Related articles   
     
     
     
138. DE RIDDER L , Van Dieren JM, Van Deventer HJ, Stokkers PC, et al
     Pharmacogenetics of thiopurine therapy in paediatric IBD patients.
     Aliment Pharmacol Ther. 2006;23:1137-41.
     PubMed     Related articles    Abstract available
     
     
     
139. SANDS BE , Blank MA, Diamond RH, Barrett JP, et al
     Maintenance infliximab does not result in increased abscess development in fistulizing Crohn's disease: results from the ACCENT II study.
     Aliment Pharmacol Ther. 2006;23:1127-36.
     PubMed     Related articles    Abstract available
     
     
     
140. PRANTERA C , Lochs H, Campieri M, Scribano ML, et al
     Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin.
     Aliment Pharmacol Ther. 2006;23:1117-25.
     PubMed     Related articles    Abstract available
     
     
     
141. CANAVAN C , Abrams KR, Mayberry J
     Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease.
     Aliment Pharmacol Ther. 2006;23:1097-104.
     PubMed     Related articles    Abstract available
     
     
     
142. PARDI DS , Sandborn WJ
     Systematic review: the management of pouchitis.
     Aliment Pharmacol Ther. 2006;23:1087-96.
     PubMed     Related articles    Abstract available
     
     
     
143. GIBSON PR , Fixa B, Pekarkova B, Batovsky M, et al
     Comparison of the efficacy and safety of Eudragit-L-coated mesalazine tablets with ethylcellulose-coated mesalazine tablets in patients with mild to moderately active ulcerative colitis.
     Aliment Pharmacol Ther. 2006;23:1017-26.
     PubMed     Related articles    Abstract available
     
     
     
144. GILMAN J , Shanahan F, Cashman KD
     Altered levels of biochemical indices of bone turnover and bone-related vitamins in patients with Crohn's disease and ulcerative colitis.
     Aliment Pharmacol Ther. 2006;23:1007-16.
     PubMed     Related articles    Abstract available
     
     
     
145. BERGMAN R , Parkes M
     Systematic review: the use of mesalazine in inflammatory bowel disease.
     Aliment Pharmacol Ther. 2006;23:841-55.
     PubMed     Related articles    Abstract available
     
     
     March 2006
146. FEAGAN BG , Sandborn WJ, Lichtenstein G, Radford-Smith G, et al
     CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, for steroid-dependent Crohn's disease: a randomized, double-blind, placebo-controlled trial.
     Aliment Pharmacol Ther. 2006;23:617-28.
     PubMed     Related articles    Abstract available
     
     
     February 2006
147. DOMENECH E , Gomollon F, Obrador A, Panes J, et al
     Is oral ciclosporin necessary to switch from i.v. to thiopurines?
     Aliment Pharmacol Ther. 2006;23:555-6.
     PubMed     Related articles   
     
     
     
148. DILGER K , Alberer M, Busch A, Enninger A, et al
     Pharmacokinetics and pharmacodynamic action of budesonide in children with Crohn's disease.
     Aliment Pharmacol Ther. 2006;23:387-96.
     PubMed     Related articles    Abstract available
     
     
     
149. CANAVAN C , Abrams KR, Hawthorne B, Drossman D, et al
     Long-term prognosis in Crohn's disease: factors that affect quality of life.
     Aliment Pharmacol Ther. 2006;23:377-85.
     PubMed     Related articles    Abstract available
     
     
     January 2006
150. GROSS V , Bar-Meir S, Lavy A, Mickisch O, et al
     Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis.
     Aliment Pharmacol Ther. 2006;23:303-12.
     PubMed     Related articles    Abstract available
     
     
     
151. BRUNNER M , Lackner E, Exler PS, Fluiter HC, et al
     5-aminosalicylic acid release from a new controlled-release mesalazine formulation during gastrointestinal transit in healthy volunteers.
     Aliment Pharmacol Ther. 2006;23:137-44.
     PubMed     Related articles    Abstract available
     
     
     December 2005
152. DULEY JA , Chocair PR, Florin TH
     Observations on the use of allopurinol in combination with azathioprine or mercaptopurine.
     Aliment Pharmacol Ther. 2005;22.
     PubMed     Related articles   
     
     
     
153. NIELSEN AA , Jorgensen LG, Nielsen JN, Eivindson M, et al
     Omega-3 fatty acids inhibit an increase of proinflammatory cytokines in patients with active Crohn's disease compared with omega-6 fatty acids.
     Aliment Pharmacol Ther. 2005;22.
     PubMed     Related articles    Abstract available
     
     
     
154. DOMENECH E , Hinojosa J, Nos P, Garcia-Planella E, et al
     Clinical evolution of luminal and perianal Crohn's disease after inducing remission with infliximab: how long should patients be treated?
     Aliment Pharmacol Ther. 2005;22.
     PubMed     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: